or
forgot password
  • cancer clinical trials in tennessee

  • A Study of Tarceva After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors
    Sarah Cannon Cancer Center

    Trial Locations
    Sarah Cannon Cancer Center
    Sarah Cannon Research Institute
    Non-small Cell Lung Cancer
    S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
    Christine LaGuardia Phillips Cancer Center at Wellmont Holston Valley Medical Center
    Kingsport, Tennessee 37662
    Lymphoma
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Vanderbilt-Ingram Cancer Center Cool Springs

    Trial Locations
    Vanderbilt-Ingram Cancer Center Cool Springs
    Thompson Cancer Survival Center
    The Center for Biomedical Research
    East Tennessee Baptist Hospital-Mercy Health Partners
    University of Tennessee - Knoxville
    University of Tennessee - Memphis
    Vanderbilt University
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
    St. Jude Children's Research Hospital

    Trial Locations
    St. Jude Children's Research Hospital
    Vanderbilt-Ingram Cancer Center
    Stage III Wilms Tumor, Stage IV Wilms Tumor
    S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
    West Tennessee Cancer Center at Jackson-Madison County General Hospital
    Jackson, Tennessee 38301
    Breast Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Christine LaGuardia Phillips Cancer Center at Wellmont Holston Valley Medical Center

    Trial Locations
    Christine LaGuardia Phillips Cancer Center at Wellmont Holston Valley Medical Center
    Thompson Cancer Survival Center
    U.T. Medical Center Cancer Institute
    University of Tennessee Cancer Institute - Memphis
    Breast Cancer
    Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma
    Tennessee Oncology
    Nashville, Tennessee 37203
    Melanoma
    First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
    Research Site
    Chattanooga, Tennessee
    Colorectal Cancer
    Study To Assess Long Term Safety Of Pazopanib
    GSK Investigational Site
    Germantown, Tennessee 38138
    Cancer
    Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
    University of Tennessee - Knoxville
    Knoxville, Tennessee 37920
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer
    Tennessee Oncology, PLLC

    Trial Locations
    Tennessee Oncology, PLLC
    Family Cancer Center
    Ovarian Cancer
    Erlotinib and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Advanced Adult Primary Liver Cancer, Carcinoma of the Appendix, Gastrointestinal Stromal Tumor, Metastatic Gastrointestinal Carcinoid Tumor, Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Adult Primary Liver Cancer, Recurrent Anal Cancer, Recurrent Basal Cell Carcinoma of the Lip, Recurrent Colon Cancer, Recurrent Esophageal Cancer, Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Recurrent Extrahepatic Bile Duct Cancer, Recurrent Gallbladder Cancer, Recurrent Gastric Cancer, Recurrent Gastrointestinal Carcinoid Tumor, Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Recurrent Lymphoepithelioma of the Nasopharynx, Recurrent Lymphoepithelioma of the Oropharynx, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Non-small Cell Lung Cancer, Recurrent Pancreatic Cancer, Recurrent Rectal Cancer, Recurrent Salivary Gland Cancer, Recurrent Small Intestine Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Small Intestine Adenocarcinoma, Small Intestine Leiomyosarcoma, Small Intestine Lymphoma, Stage IV Adenoid Cystic Carcinoma of the Oral Cavity, Stage IV Anal Cancer, Stage IV Basal Cell Carcinoma of the Lip, Stage IV Colon Cancer, Stage IV Esophageal Cancer, Stage IV Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Stage IV Gastric Cancer, Stage IV Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Lymphoepithelioma of the Oropharynx, Stage IV Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Stage IV Mucoepidermoid Carcinoma of the Oral Cavity, Stage IV Non-small Cell Lung Cancer, Stage IV Pancreatic Cancer, Stage IV Rectal Cancer, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Unresectable Extrahepatic Bile Duct Cancer, Unresectable Gallbladder Cancer
    Safety Study of PLX4032 in Patients With Solid Tumors
    Vanderbilt Ingram Cancer Center
    Nashville, Tennessee 37232
    Malignant Melanoma, Colorectal Carcinoma
    Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer
    Chattanooga Oncology & Hematology Associates

    Trial Locations
    Chattanooga Oncology & Hematology Associates
    Tennessee Oncology, PLLC
    Breast Cancer, Breast Neoplasms
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
    Thompson Cancer Survival Center

    Trial Locations
    Thompson Cancer Survival Center
    University of Tennessee Cancer Institute - Memphis
    MBCCOP - Meharry Medical College - Nashville
    Nashville Oncology Associates, PC
    Breast Cancer
    Single Versus Double Umbilical Cord Blood Transplantation in Children With High Risk Leukemia and Myelodysplasia
    Vanderbilt University Medical Center
    Nashville, Tennessee 37232-2516
    Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic Syndrome, NK Cell Lymphoblastic Leukemia
    Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections

    Nashville, Tennessee 37203-1632
    Mycoses, Candidiasis, Invasive, Candidemia
    Fludeoxyglucose F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Small Cell Carcinoma, Cervical Squamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Endometrial Papillary Serous Carcinoma, Stage I Endometrial Carcinoma, Stage IB Cervical Cancer, Stage II Endometrial Carcinoma, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage III Endometrial Carcinoma, Stage IVA Cervical Cancer
    Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer
    Christine LaGuardia Phillips Cancer Center at Wellmont Holston Valley Medical Center
    Kingsport, Tennessee 37662
    Anal Cancer
    Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
    Christine LaGuardia Phillips Cancer Center at Wellmont Holston Valley Medical Center

    Trial Locations
    Christine LaGuardia Phillips Cancer Center at Wellmont Holston Valley Medical Center
    MBCCOP - Meharry Medical College - Nashville
    Prostate Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Vanderbilt-Ingram Cancer Center Cool Springs

    Trial Locations
    Vanderbilt-Ingram Cancer Center Cool Springs
    Wellmont Holston Valley Hospital and Medical Center
    Thompson Cancer Survival Center
    University of Tennessee - Knoxville
    University of Tennessee - Memphis
    Vanderbilt University
    Meharry Medical College
    Nashville Oncology Associates PC
    Vanderbilt Breast Center at One Hundred Oaks
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Cognitive/Functional Effects, Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment
    Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
    H. Clay Evans Johnson Cancer Center at Memorial Hospital

    Trial Locations
    H. Clay Evans Johnson Cancer Center at Memorial Hospital
    Thompson Cancer Survival Center
    U.T. Medical Center Cancer Institute
    Lung Cancer
    Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine in Treating Patients With Fanconi Anemia
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Childhood Acute Myeloid Leukemia in Remission, Childhood Myelodysplastic Syndromes, de Novo Myelodysplastic Syndromes, Fanconi Anemia, Previously Treated Myelodysplastic Syndromes
    PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response
    Research Site
    Chattanooga, Tennessee
    Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck
    High-dose Bevacizumab in Advanced Renal Carcinoma Patients
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Renal Cancer, Kidney Cancer